Skip to main
AVBP
AVBP logo

AVBP Market Capitalization Overview

Market Cap: $721.89M as of Jul 2, 2025

$721.89M
Past Month-$30.80M (4.09%)
As of Jul 2, 2025, AVBP has a market capitalization of $721.89M. Over the past 30 days, its market cap has decreased by -5.05%, while in the last 12 months, it has decreased by -19.58%.

Market capitalization represents the total value of ArriVent Biopharma Inc as perceived by the stock market. It is calculated by multiplying the current stock price by the total number of outstanding shares.

AVBP Market Cap Formula = Stock Price * Shares Outstanding

The market cap of AVBP helps investors assess the company's size and compare it with competitors for better investment decisions.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

AVBP Market Cap History

DateMarket CapChange
Jul 1, 2025$714.71M-5.05%
Jun 2, 2025$752.68M+4.97%
May 1, 2025$717.07M+16.92%
Apr 1, 2025$613.32M-17.38%
Mar 3, 2025$742.35M-20.07%
Feb 3, 2025$928.70M+0.33%
Jan 2, 2025$925.67M-7.07%

AVBP End of Year Market Cap History

DateMarket CapChange
2025$721.89M-19.58%
2024$897.70M

FAQs About ArriVent Biopharma Inc (AVBP) Market Cap

As of Jul 2, 2025, the market capitalization of AVBP is $721.89M. Market cap represents the total value of a company’s outstanding shares and is a key indicator of its size in the stock market.

In the last 30 days, ArriVent Biopharma Inc’s market capitalization has decreased by -4.09%, changing from $752.68M to $721.89M as of Jul 2, 2025.

In the last 3 months, ArriVent Biopharma Inc’s market capitalization has increased by —, changing from – to – as of –.

In the year 2024, ArriVent Biopharma Inc’s market capitalization increased from – in January to $897.70M in December, reflecting a — change.

ArriVent Biopharma Inc (AVBP)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.